Lifeward gets FDA Clearance for its newest exoskeleton device (LFWD:NASDAQ)


Close-up on a man using a powered exoskeleton during his physical therapy

Hispanolistic/E+ via Getty Images

  • Lifeward (NASDAQ:LFWD) stock soared on Thursday after it has received 510((k)) FDA clearance for its new personal exoskeleton device, the ReWalk 7.
  • LFWD is up 42% in morning trade.
  • The company said that the seventh generation of the ReWalk, a



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top